ANTX Competitors & Alternatives
Compare AN2 Therapeutics Inc with similar stocks in the same industry
Biotechnology
ANTX
Main Stock$5.00
Tradestie Score
58
Market Cap
$35.25M
Analyst Upside
+80.0%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.00
|
$275.13M | - | 55 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.49
|
$269.08M | - | 57 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.05
|
$211.22M | - | 57 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.50
|
$202.58M | - | 57 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.70
|
$170.45M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.85
|
$158.43M | - | 55 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.45
|
$133.50M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$22.74
|
$110.20M | - | 55 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$2.26
|
$106.00M | - | 54 | Compare |
More ANTX Analysis
Data updated: Jun 22, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry